Please login to the form below

Not currently logged in
Email:
Password:

Conatus Pharmaceuticals

This page shows the latest Conatus Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Novartis buys two firms in pre-Christmas shopping spree

Novartis buys two firms in pre-Christmas shopping spree

The Swiss pharma major is paying $50m upfront to license a non-alcoholic steatohepatitis (NASH) drug candidate developed by Californian firm Conatus Pharmaceuticals and buying out Texas-based eye disease specialist ... Conatus has the option to

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Virtual Steering Committee & Peer Influence Program
In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
Meeting healthcare’s rising challenges
The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
Report gives insights to address gaps in HCP engagement
How does Pharma-HCP engagement need to evolve in today's digital landscape?...